Bis‐Pyrano Prenyl Isoflavone Improves Glucose Homeostasis by Inhibiting Dipeptidyl Peptidase‐4 in Hyperglycemic Rats

• Published in: Journal of cellular biochemistry 2017-01, Vol.118 (1), p.92-103
• Main Authors: Altenhofen, Delsi, da Luz, Gabrielle, Frederico, Marisa Jádna Silva, Venzke, Dalila, Brich, Mayara, Vigil, Silvana, Fröde, Tania Silvia, Linares, Carlos Eduardo Blanco, Pizzolatti, Moacir Geraldo, Silva, Fátima Regina Mena Barreto
• Format: Article
• Language: English
• Subjects: Animals; Blood Glucose - metabolism; CALCIUM; DIABETES; Dipeptidyl Peptidase 4 - blood; Dipeptidyl-Peptidase IV Inhibitors - chemistry; Dipeptidyl-Peptidase IV Inhibitors - pharmacology; Glucagon-Like Peptide 1 - blood; GLYCAEMIA; Hyperglycemia - blood; Hyperglycemia - drug therapy; INCRETIN; INSULIN; Insulin - blood; ISOFLAVONES; Isoflavones - chemistry; Isoflavones - pharmacology; Male; Polygala - chemistry; Rats; Rats, Wistar; Sitagliptin Phosphate - pharmacology
• ISSN: 0730-2312; 1097-4644
• DOI: 10.1002/jcb.25614

ABSTRACT Isoflavones widely distributed in plants prevent diabetes. This study investigated the in vivo and in vitro effect of 3′,4′‐dihydroxy‐6″,6″,6″′,6″′‐tetramethylbis(pyrano[2″,3″:5,6::2″′,3″′:7,8]isoflavone (bis‐pyrano prenyl isoflavone) on glucose homeostasis in hyperglycemic rats. The ethyl acetate fraction from aerial parts of Polygala molluginifolia that contain isoflavones was assayed on glucose tolerance, on in vitro maltase activity and on protein glycation. The isoflavone bis‐pyrano prenyl isolated from this fraction was investigated on glucose homeostasis. The in vivo action of the isoflavone exhibits an anti‐hyperglycemic effect by improving glucose tolerance, augmenting the liver glycogen, inhibiting maltase activity, and stimulating glucagon‐like peptide‐1 (GLP‐1) and insulin secretion. The in vitro isoflavone inhibits dipeptidyl peptidase‐4 (DPP‐4) activity since the glucose tolerance was improved in the presence of the isoflavone as much as sitagliptin, an inhibitor of DPP‐4. However, the co‐incubation with isoflavone and sitagliptin exhibited an additive anti‐hyperglycemic action. The isoflavone increased the GLP‐1 faster than the positive hyperglycemic group, which shows that the intestine is a potential target. Thus, to clarify the main site of action in which isoflavone improves glucose balance, the in vitro mechanism of action of this compound was tested in intestine using calcium influx as a trigger for the signal pathways for GLP‐1 secretion. The isoflavone stimulates calcium influx in intestine and its mechanism involves voltage‐dependent calcium channels, phospholipase C, protein kinase C, and stored calcium contributing for GLP‐1 secretion. In conclusion, the isoflavone regulates glycaemia by acting mainly in a serum target, the DPP‐4 inhibitor. Furthermore, the long‐term effect of isoflavone prevents protein glycation. J. Cell. Biochem. 118: 92–103, 2017. © 2016 Wiley Periodicals, Inc. This study investigated the in vivo and in vitro effect of 3′,4′‐dihydroxy‐6″,6″,6″′,6″′‐tetramethylbis(pyrano[2″,3″:5,6::2″′,3″′:7,8]isoflavone (bis‐pyrano prenyl isoflavone) on glycaemia in hyperglycemic rats. The acute in vivo action of the isoflavone exhibits an anti‐hyperglycemic effect by improving glucose tolerance, augmenting the liver glycogen, inhibiting maltase activity, and stimulating glucagon‐like peptide‐1 (GLP‐1) and insulin secretion. In addition, the in vitro isoflavone seems to inhibit dipeptidyl peptidase‐4 (DPP‐4) activity